Results
1 -
10 of
12
(Click
here to explore results)
- Neglected Diseases and Drug Discovery, Chapter 6 Drugs for Kinetoplastid Diseases – Current Situation and Challenges. Simon L. Croft
, 2012
, Pages 134-158
- Neglected Diseases and Drug Discovery, Chapter 7 Drug Discovery for Kinetoplastid Diseases. Robert T. Jacobs
, 2012
, Pages 159-202
- Polyamine Drug Discovery, Chapter 11 Clinical Applications of Polyamine-Based Therapeutics. André S. Bachmann, Victor A. Levin
, 2012
, Pages 257-276
- Polyamine Drug Discovery, Chapter 4 Inhibitors of Polyamine Biosynthetic Enzymes. Anthony E. Pegg
, 2012
, Pages 78-103
- Electron Paramagnetic Resonance: Volume 19, Biomedical aspects of free radicals: Recent developments through the application of EPR. B. C. Gilbert, M. J. Davies, D. M. Murphy, Mark J. Burkitt
, 2004
, Volume 19
, Pages 33-81
- Organoselenium Compounds in Biology and Medicine: Synthesis, Biological and Therapeutic Treatments, Chapter 11 Ebselen and Thioredoxin Systems in Human Health, Disease and Therapeutic Potential. Jun Lu, Xiaoyuan Ren, Lili Zou, Arne Holmgren
, 2018
, Pages 303-316
- Polyamine Drug Discovery, Chapter 3 Antiparasitic Drug Discovery for the Polyamine Pathway. Nigel Yarlett, Mary Morada
, 2012
, Pages 50-77
- Drug Discovery for Leishmaniasis, Chapter 8 Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs. Ana Martinez, Carmen Gil
, 2018
, Pages 153-178
- Drug Discovery for Leishmaniasis, Chapter 2 Anti-leishmanial Drug Discovery: Past, Present and Future Perspectives. Charles E. Mowbray
, 2018
, Pages 24-36
- Drug Discovery for Leishmaniasis, Chapter 6 Omics and Their Impact on the Development of Chemotherapy Against Leishmania. Christopher Fernández-Prada, Isabel M. Vincent, Élodie Gazanion, Rubens L. Monte-Neto
, 2018
, Pages 101-129